Humans
Sign up for our newsletter
We summarize the week's scientific breakthroughs every Thursday.
-
HumansScience News of the Year 2000
A review of important scientific achievements reported in Science News during the year 2000.
By Science News -
Health & MedicineDrugs counteract irritable bowel syndrome
Antibiotics can knock out bacteria overload in the small intestine, temporarily reversing irritable bowel syndrome.
By Nathan Seppa -
-
Health & MedicineAntibiotics, vitamins stall stomach cancer
A 6-year study shows that vitamin C, beta-carotene, and antibiotics can reverse premalignant conditions that could otherwise lead to stomach cancer.
By Nathan Seppa -
Health & MedicineOld and new drugs may fight myeloma
In some people with a bone marrow cancer called multiple myeloma, treatment with thalidomide or PS-341, which induces programmed cell death, may improve their chances of survival.
By Nathan Seppa -
Health & MedicineTrials affirm value of drug
The drug STI-571, previously shown to work against chronic myelogenous leukemia, also helps patients who have slipped into an acute, highly lethal form of this cancer.
By Nathan Seppa -
Health & MedicineWeight Matters, Even in the Womb
Status at birth can foreshadow illnesses decades later.
-
Health & MedicineDrug aids destruction of lymphoma cells
The drug rituximab, when added to chemotherapy, boosts survival rates in people with diffuse B-cell lymphoma, a kind of cancer.
By Nathan Seppa -
Health & MedicineIs penicillin-allergy rate overstated?
A study finds that 20 of 21 people who reported having a penicillin allergy when filling out paperwork during a hospital visit in fact don't have one, suggesting that the prevalence of this allergy is overstated.
By Nathan Seppa -
Health & MedicineMarker signals esophageal cancer
Silencing of the gene that encodes the cancer-suppressing protein APC is common in people with esophageal cancer, suggesting that physicians might use this genetic abnormality as a marker for the disease.
By Nathan Seppa -
Health & MedicineVaccine protects monkeys from Ebola virus
A combination of a DNA vaccine and a vaccine based on a genetically modified common cold virus enables monkeys to resist Ebola virus, the first evidence that an Ebola vaccine works in primates.
By Nathan Seppa -
Health & MedicineNew sources and uses for stem cells
Human skin and scalp tissue may provide a source of neural stem cells.
By John Travis